Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Jun 1;24(1):645.
doi: 10.1186/s12903-024-04379-3.

Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial)

Basma Elsaadany  1 , Samah M Anayb  2 , Karim Mashhour  3 , Mohammed Yossif  4 , Fat'heya Zahran  2
Affiliations
Clinical Trial

Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial)

Basma Elsaadany et al. BMC Oral Health. .

Abstract

Objectives: This study aimed to evaluate the preventive and therapeutic effects of rebamipide gargle in comparison with benzydamine in head and neck cancer patients undergoing radiotherapy with or without chemotherapy.

Materials and methods: Phase III randomized clinical trial was conducted from January 2021 till August 2022 on one hundred patients with head and neck cancer receiving high doses of radiotherapy. These patients were equally allocated into either rebamipide group or benzydamine group, The measured outcomes were the incidence of oral mucositis ≥ grade1, according to the WHO mucositis scale, in addition to the duration, and the onset of oral mucositis.

Results: There was no statistically significant difference between the two groups, regarding the incidence of a severe grade of oral mucositis (WHO grades 3), as well as the onset and duration of oral mucositis. Both gargles succeeded to prevent the development of WHO grade 4 oral mucositis. Side effects reported were mainly burning sensation in benzydamine group and nausea in rebamipide group.

Conclusion: Rebamipide mouthwash was as beneficial as benzydamine mouthwash in minimizing the incidence of severe oral mucositis induced by treatment of head and neck cancer. However, rebamipide gargle proved to be superior to benzydamine in terms of reduction in the severity of the radiation-induced oral mucositis.

Trial registration: The trial was registered in the protocol Registration and Result system of Clinical Trials (Registration ID: NCT04685395)0.28-12-2020.

Keywords: Benzydamine HCl; Chemoradiotherapy; Head & neck cancer; Oral mucositis; Radiotherapy; Rebamipide.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of participants enrollment and analysis
Fig. 2
Fig. 2
Bar chart showing the incidence of oral mucositis in participants who received radiotherapy with or without chemotherapy
Fig. 3
Fig. 3
Bar chart showing a maximum grade of oral mucositis among the participants who received radiotherapy with or without chemotherapy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Hui Huang S, Brian MO. Overview of the 8th Edition TNM classification for Head and Neck Cancer. Options Oncol. 2017;18:40. doi: 10.1007/s11864-017-0484-y. - DOI - PubMed
    1. Guo K, Xiao W, Chen X, Zhao Z, Lin Y, Chen G. Epidemiological trends of Head and Neck Cancer: a Population-based study. Biomed Res Int. 2021;2021. 10.1155/2021/1738932. - PMC - PubMed
    1. Hashim D, et al. Hormone factors play a favorable role in female head and neck cancer risk. Cancer Med. 2017;6(8):1998–2007. doi: 10.1002/cam4.1136. - DOI - PMC - PubMed
    1. Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A. An updated review on head and neck cancer treatment with radiation therapy. Cancers (Basel) 2021;13(19):4912. doi: 10.3390/cancers13194912. - DOI - PMC - PubMed
    1. Curra M, Soares Junior LAV, Martins MD, Santos PS. Protocolos quimioterápicos e incidência de mucosite bucal. Revisão integrativa, Einstein (São Paulo). 2018;16:1–9. - PMC - PubMed

Publication types

Associated data